Helsinn Group (“Helsinn”), a fully integrated global biopharma company with a track record of over forty years of commercial execution and a st...
SARS-CoV-2 spike protein (B.1.351 strain) vaccine is the first and only protein-based variant COVID-19 booster vaccine approved in Great Britain and the ...
Vaxart, Inc., a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, an...
© 2026 Biopharma Boardroom. All Rights Reserved.
